If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 181 - 190 of 289
A Phase 3 Randomized, Open-Label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Previously Treated with Next-Generation Hormonal Agent (NHA) and Tax
Objective
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
Protocol No
MERCK-MK-5684-003
Categories
MODERN: An Integrated Phase 2/3 and Phase 3 Trial of MRD-Based Optimization of Adjuvant Therapy in Urothelial Cancer
Objective
Testing the role of DNA released from tumor cells into the blood in guiding the use of immunotherapy after surgical removal of the bladder for bladder cancer treatment.
Protocol No
ALLIANCE-A032103-MODERN
Categories
A Randomized Study Comparing the Efficacy of the Combination of Doxorubicin and the Tumor-Targeting Human Antibody-Cytokine Fusion Protein L19TNF to Doxorubicin Alone as First-Line Therapy in Patients with Metastatic Leiomyosarcoma
Objective
L19TNF treatment of metastatic soft tissue sarcoma patients
Protocol No
PHILOGEN-PH-L19TNFDOX2-02-17
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/LY3650150 in Participants with Chronic Rhinosinusitis with Nasal Polyps on Background Intranasal Corticoste
Objective
Lebrikizumab vs. Placebo w/ Steroids in CRSwNP
Protocol No
OTO-ELILILLY-J2T-MC-KGBU
Categories
A Phase Ib Study of Talquetamab Bridging Therapy Followed by Ciltacabtagene Autoleucel in Patients with Relapsed/Refractory Multiple Myeloma
Objective
Study of talquetamab in patients with R/R multiple myeloma
Protocol No
IIT-AKHTAR-CILTA-TALQ
Categories
A Modular Phase II, Single-Arm, Multicenter, Open-Label Study to Evaluate the Efficacy and Safety of AZD0486 in Participants with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (SOUNDTRACK-B)
Objective
We are doing this study to learn more about the experimental treatment AZD0486, to learn if the study drug will be safe, tolerable and effective in treating the type of lymphoma that you have.
Protocol No
AZ-D7404C00001-SOUNDTRACK-B
Categories
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk: A Randomized Trial
Objective
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
Protocol No
SURG-NHLBI-LEADER-PAD
PREcision DIagnostics in Prostate Cancer Treatment (PREDICT)
Objective
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial (PREDICT)
Protocol No
ALLIANCE-A032102
Categories
An Open-Label Phase 1b Study Evaluating the Safety and Efficacy of Etentamig (ABBV-383) in AL Amyloidosis
Objective
Study of ABBV-383 for AL amyloidosis
Protocol No
ABBVIE-M24-209
Categories
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Objective
Collection of research data and samples from patients who experience immunotherapy side effects
Protocol No
ALLIANCE-A151804